This FDA approval is a testament to our commitment to advancing prostate cancer care through research and innovation. Every achievement is driven by our dedication to transforming lives and giving patients what matters most – more options.
#ReimaginingMedicine
As a part of our 20+-year commitment to innovation and support in CML, we continue to work alongside the clinical and patient communities.
#ReimaginingMedicine
For more than 2 decades, we've been working diligently to develop medicine for people living with chronic myeloid leukemia (#CML). This FDA approval reflects our ongoing commitment to that community.
#ReimaginingMedicine